TABLE 3.

Comparison of laboratory findings between mild and moderate to severe outcomes of patients with PD.

Variables	H&Y stage		P-value
	Mild group	Moderate to severe
	(n = 41)	group (n = 17)
Gender (Male/Female)	21/20	8/9	0.773
Age (years)	66.39 ± 9.15	62.47 ± 12.18	0.312
Length of hospital stay (day)	10 (5∼13)	9.5 (8∼11)	0.877
Disease duration (years)	2 (1∼4)	5 (5∼9)	<0.001
Family history [n(%)]	1 (2.44)	1 (5.88)	0.513
Dyslipidemia [n(%)]	5 (12.20)	1 (5.88)	0.472
Diabetes mellitus [n(%)]	10 (24.39)	2 (11.76)	0.280
Hypertension [n(%)]	24 (58.54)	10 (58.82)	0.984
Brain infarction [n(%)]	11 (26.83)	4 (23.53)	0.794
Smoking [n(%)]	7 (17.07)	1 (5.88)	0.261
Drinking [n(%)]	3 (7.32)	0 (0)
SBP/(mmHg)	129 (118∼140)	124 (120∼137)	0.817
DBP/(mmHg)	86 (78∼91)	81 (80∼86)	0.694
H&Y stage	1.5 (1∼2)	3 (2.5∼3)	<0.001
ALT/(U/L)	17 (10∼23)	12.5 (8∼15)	0.884
AST/(U/L)	19 (17∼23)	19.5 (18∼21)	0.503
ALP/(U/L)	74 (60∼83)	68.5 (65∼74)	0.918
BUN/(mmol/L)	4.59 (3.89∼5.73)	4.46 (3.55∼5.28)	0.174
Cr/(μmol/L)	65.7 (54.8∼80.7)	64.8 (61.3∼86.2)	0.585
UA/(μmol/L)	258.4 (210∼299.4)	323.7 (246.2∼398.7)	0.494
Cys C/(mg/L)	0.99 (0.86∼1.10)	1.02 (0.90∼1.16)	0.945
Glu/(mmol/L)	5.00 (4.46∼5.57)	4.85 (4.60∼5.27)	0.462
TC/(mmol/L)	4.47 (3.64∼5.02)	4.10 (3.68∼4.83)	0.573
TG/(mmol/L)	0.86 (0.69∼1.22)	1.07 (0.63∼1.25)	0.688
HDL/(mmol/L)	1.29 (1.08∼1.60)	1.34 (1.02∼1.41)	0.952
LDL/(mmol/L)	2.66 (1.95∼2.98)	2.35 (1.90∼3.01)	0.489
CER/(mg/L)	240 (231∼263)	242.5 (222∼292)	0.927
SAA/(mg/L)	7.0 (5.1∼10.8)	7.0 (4.7∼10.9)	0.785
HCY/(μmol/L)	14.4 (10.8∼19.2)	14.6 (13.7∼16.4)	0.785
Lp-PLA2/(ng/mL)	117 (100∼196)	317 (282∼381)	<0.001